<DOC>
	<DOCNO>NCT00486785</DOCNO>
	<brief_summary>Primary Objective : - To assess sexual function improvement baseline end treatment ( Week 24 premature withdrawal ( PW ) ) XATRAL 10mg OD . Secondary Objective : - To evaluate association Lower Urinary Tract Symptoms ( LUTS ) severity sexual disorder , - To compare improvement sexual function , urinary symptom Quality Life among different region , - To correlate MSHQ ( Male Sexual Health Questionnaire ) IIEF-5 ( 5-Item version International Index Erectile Function ) , - To assess onset action XATRAL 10mg OD , - To assess peak flow rate improvement ( Qmax ) , - To assess safety tolerability XATRAL 10mg OD .</brief_summary>
	<brief_title>SAMBA : Sexuality And Management Benign Prostatic Hyperplasia With Alfuzosin</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Patients suffer moderate severe low urinary tract symptom ( LUTS ) , suggestive symptomatic Benign Prostatic Hyperplasia ( BPH ) , Patients IPSS total score ≥ 8 , Patients sexually active Known history hepatic severe renal insufficiency , unstable angina pectoris , concomitant threateninglife condition . Previous prostate surgery , minimally invasive procedure within 6 month prior inclusion . Planned prostate biopsy , prostate surgery minimally invasive procedure whole study period . Active urinary tract infection prostatitis , neuropathic bladder , diagnosed prostate cancer . Patients receive 5αreductase inhibitor LUTS relate phytotherapy within 6 month prior inclusion , α1blockers within 30 day prior inclusion . Patients receive treatment erectile dysfunction ( i.e . phosphodiesterase5 inhibitor ) inclusion . History postural hypotension syncope . Known hypersensitivity alfuzosin . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>